FMBH
First Mid Bancshares, Inc.
FMBH offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over FMBH overall, supported by stronger modeled upside and lower modeled downside.
FMBH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FMBH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FMBH.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
FMBH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.2x | $39.79 | -22% |
| Fair | 11x | $46.53 | -9.1% |
| Forward | 11x | $51.19 | — |
| Current | 12x | $51.19 | — |
| Expensive | 13x | $56.93 | +11% |
Historical ranges are pointers, not guarantees.
FMBH's PE is in its expensive range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over FMBH in the historical PE scenario, which offers more potential upside but is not a forecast.
FMBH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FMBH, with profitability holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
FMBH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.75 | +9.6% |
| Q3 2026 | $4.33 | +18% |
| Q2 2026 | $4.02 | +14% |
| Q1 2026 | $3.96 | +18% |
| Q4 2025 | $3.83 | +16% |
| Q3 2025 | $3.66 | +13% |
| Q2 2025 | $3.53 | +14% |
| Q1 2025 | $3.37 | +9.4% |
| Q4 2024 | $3.30 | +4.8% |
FMBH's earnings per share have climbed steadily: $4.33 over the past year, up 18% from the year before, and higher year over year for eight quarters in a row.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over FMBH on earnings, with stronger typical year-over-year growth.
FMBH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $106.6M | +19% |
| Q2 2026 | $108.5M | +24% |
| Q1 2026 | $97.2M | +15% |
| Q4 2025 | $88.2M | +3.4% |
| Q3 2025 | $89.3M | +11% |
| Q2 2025 | $87.5M | +10% |
| Q1 2025 | $84.3M | +5.4% |
| Q4 2024 | $85.3M | +7.7% |
FMBH has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +7.1 points |
| Q2 2026 | 33% | -1 points |
| Q1 2026 | 35% | +1.5 points |
| Q4 2025 | 34% | +4.3 points |
| Q3 2025 | 32% | +0.7 points |
| Q2 2025 | 34% | +0.7 points |
| Q1 2025 | 33% | -0.3 points |
| Q4 2024 | 30% | +2.4 points |
FMBH's operating margin was 39% last quarter, up 7.1 points from the same quarter a year ago, near the top of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over FMBH on profitability, with a higher operating margin.
FMBH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $45.8M | +43% |
| Q2 2026 | $24.2M | +305% |
| Q1 2026 | $23.1M | -50% |
| Q4 2025 | $40.2M | +8.5% |
| Q3 2025 | $31.9M | -0.3% |
| Q2 2025 | $6M | -74% |
| Q1 2025 | $46M | +67% |
| Q4 2024 | $37M | +31% |
FMBH has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
FMBH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -3K shares |
| 1 year | +11% | +2.6M shares |
| 3 years | +19% | +4.3M shares |
| 5 years | +47% | +8.5M shares |
| Available history | +59% | +9.9M shares |
FMBH has 27M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $921,000 |
| Q1 2026 | $500,000 |
| Q4 2024 | $659,000 |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $460,000 |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over FMBH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
FMBH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2020 | -0.8x | Net Cash |
| Q4 2019 | -1.2x | Net Cash |
FMBH has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FMBH.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
FMBH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.6 | Neutral |
| Stochastic | 53.0 | Neutral |
FMBH's weekly RSI is 62 (neutral) and its Stochastic is 53 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
FMBH PE vs Financial Services Sector
| Metric | FMBH | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9.2% below |
| PE % | 66 | 63 | 3 pts above |
FMBH has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
FMBH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $50.1 | 2.2% above |
| 20 week MA | $50.3 | 1.8% above |
| 50 week MA | $45.6 | 12% above |
| 100 week MA | $41.2 | 24% above |
| 200 week MA | $36.5 | 40% above |
FMBH has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
FMBH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.3 | $33.5 | -5.1% |
| 2021 | $33.5 | $42.6 | +27% |
| 2022 | $42.6 | $32.2 | -24% |
| 2023 | $32.2 | $34.7 | +7.7% |
| 2024 | $34.7 | $37.0 | +6.7% |
| 2025 | $37.0 | $40.0 | +8.1% |
| 2026 YTD | $40.0 | $51.2 | +28% |
FMBH has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.